Literature DB >> 16849447

Cutting edge: unique T cells that recognize citrullinated peptides are a feature of protein immunization.

Jamie Ireland1, Jeremy Herzog, Emil R Unanue.   

Abstract

Abs against citrullinated proteins are present in patients with rheumatoid arthritis. In this study, we describe a unique cohort of T cells that selectively responded to citrullinated variants of two epitopes of hen egg-white lysozyme, a major and a minor one, bound to the MHC molecule, I-A(k). In addition, we show that when given an intact, unmodified lysozyme protein, dendritic cells and peritoneal macrophages presented citrullinated peptides and stimulated modification-specific T cells. Thus, presentation of citrullinated-peptide-MHC complex is a feature of immune responses to protein Ags.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16849447     DOI: 10.4049/jimmunol.177.3.1421

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  18 in total

1.  Citrullination of proteins: a common post-translational modification pathway induced by different nanoparticles in vitro and in vivo.

Authors:  Bashir M Mohamed; Navin K Verma; Anthony M Davies; Aoife McGowan; Kieran Crosbie-Staunton; Adriele Prina-Mello; Dermot Kelleher; Catherine H Botting; Corey P Causey; Paul R Thompson; Ger Jm Pruijn; Elena R Kisin; Alexey V Tkach; Anna A Shvedova; Yuri Volkov
Journal:  Nanomedicine (Lond)       Date:  2012-05-25       Impact factor: 5.307

Review 2.  Regulation of CD4 T-cell receptor diversity by vaccine adjuvants.

Authors:  Christina K Baumgartner; Laurent P Malherbe
Journal:  Immunology       Date:  2010-03-17       Impact factor: 7.397

Review 3.  Antibodies to citrullinated proteins: pathogenic and diagnostic significance.

Authors:  V Michael Holers
Journal:  Curr Rheumatol Rep       Date:  2007-10       Impact factor: 4.592

Review 4.  The pathogenic potential of autoreactive antibodies in rheumatoid arthritis.

Authors:  Marieke Bax; Tom W J Huizinga; René E M Toes
Journal:  Semin Immunopathol       Date:  2014-04-25       Impact factor: 9.623

5.  Identification and functional characterization of T cells reactive to citrullinated vimentin in HLA-DRB1*0401-positive humanized mice and rheumatoid arthritis patients.

Authors:  Omri Snir; Mary Rieck; John A Gebe; Betty B Yue; Crystal A Rawlings; Gerald Nepom; Vivianne Malmström; Jane H Buckner
Journal:  Arthritis Rheum       Date:  2011-10

6.  N-α-benzoyl-N5-(2-chloro-1-iminoethyl)-L-ornithine amide, a protein arginine deiminase inhibitor, reduces the severity of murine collagen-induced arthritis.

Authors:  Van C Willis; Alison M Gizinski; Nirmal K Banda; Corey P Causey; Bryan Knuckley; Kristen N Cordova; Yuan Luo; Brandt Levitt; Magdalena Glogowska; Piyanka Chandra; Liudmila Kulik; William H Robinson; William P Arend; Paul R Thompson; V Michael Holers
Journal:  J Immunol       Date:  2011-02-23       Impact factor: 5.422

Review 7.  Immune recognition of citrullinated epitopes.

Authors:  Hai Nguyen; Eddie A James
Journal:  Immunology       Date:  2016-08-17       Impact factor: 7.397

8.  Protein arginine deiminase 4 inhibition is sufficient for the amelioration of collagen-induced arthritis.

Authors:  V C Willis; N K Banda; K N Cordova; P E Chandra; W H Robinson; D C Cooper; D Lugo; G Mehta; S Taylor; P P Tak; R K Prinjha; H D Lewis; V M Holers
Journal:  Clin Exp Immunol       Date:  2017-03-09       Impact factor: 4.330

9.  Detection of autoantibodies to citrullinated BiP in rheumatoid arthritis patients and pro-inflammatory role of citrullinated BiP in collagen-induced arthritis.

Authors:  Hirofumi Shoda; Keishi Fujio; Mihoko Shibuya; Tomohisa Okamura; Shuji Sumitomo; Akiko Okamoto; Tetsuji Sawada; Kazuhiko Yamamoto
Journal:  Arthritis Res Ther       Date:  2011-11-22       Impact factor: 5.156

Review 10.  Current concepts in the pathogenesis of early rheumatoid arthritis.

Authors:  Arthur G Pratt; John D Isaacs; Derek L Mattey
Journal:  Best Pract Res Clin Rheumatol       Date:  2009-02       Impact factor: 4.098

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.